Our data demonstrate that chronically demyelinated lesions show dysregulation of ID2 and ID4 both on the level of methylation and gene expression, which could be an underlying mechanisms behind the OPC differentiation block in progressive MS stages. The gene discussed is ID2; the disease is myeloid sarcoma.